Search filters

List of works by Henry Nasrallah

17. Effects of Cariprazine on Negative Symptoms, Cognitive Impairment, and Prosocial Functioning in Patients With Predominant Negative Symptoms: Post Hoc Analysis of a Phase III, Placebo-, and Active-Controlled Study.

scientific article published on 20 March 2017

25 years of editing Schizophrenia Research: A unique and gratifying journey ⬇️

scientific article published on December 8, 2012

A Valedictory from the Founding Editors

scientific article

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

scientific article

A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia

scientific article

A focus on postpartum depression among African American women: A literature review

scientific article published on 01 May 2019

A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: Possible stage-specific effects

scientific article published on November 2015

A novel approach to measuring response and remission in schizophrenia in clinical trials

scientific article published on 14 March 2017

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia

scientific article

A systematic review of diffusion tensor imaging studies in drug-naïve OCD patients before and after pharmacotherapy

scientific article published on 01 February 2020

A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities

scientific article published on 22 April 2013

Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics

scientific article published in January 2004

Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases ⬇️

scientific article published on May 8, 2013

Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials.

scientific article published on 30 September 2017

An analysis of the high psychotropic off-label use in psychiatric disorders The majority of psychiatric diagnoses have no approved drug

scientific article published on 27 February 2009

An overview of common medical comorbidities in patients with schizophrenia

scientific article published on 01 January 2005

Antipsychotic drugs

scientific article published on January 1, 2012

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

scientific article published on 04 September 2008

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database

scientific article published in August 2003

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design

scientific article published in March 2006

Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care

scientific article published in October 2004

Bidirectional relationship between transient ischemic attacks and depression: A review

scientific article published on 01 August 2019

Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies

scientific article

Body temperature rises following improvement of depression with ECT

scientific article published on 01 August 2018

CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence

scientific article published on 17 July 2013

Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature

scientific article published on 15 June 2006

Celebrating twenty years of schizophrenia research

scientific article published on 13 February 2008

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1

scientific article

Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review

scientific article published on 01 November 2019

Clinical Pharmacology of Paliperidone Palmitate A Parenteral Long-Acting Formulation for the Treatment of Schizophrenia ⬇️

scientific article published on February 1, 2012

Consequences of misdiagnosis: inaccurate treatment and poor patient outcomes in bipolar disorder

scientific article

Corrigendum to "Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial" [Schizophr. Res. 176 (2016) 264-271].

scientific article

Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology

scientific article published on 27 November 2009

Defining and measuring clinical effectiveness in the treatment of schizophrenia

scientific article

Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms.

scientific article published on 09 January 2015

Differential diagnosis and therapeutic management of schizoaffective disorder.

scientific article

Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats.

scientific article published on August 2010

Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database

scientific article

Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies

scientific article published on July 2006

Does the Neurotoxicity of Haloperidol Explain the Higher Mortality in Dementia Patients Compared With the Second Generation Agents? ⬇️

scientific article published on June 1, 2012

Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia

scientific article published on 30 August 2016

Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale-supportive analyses from a Phase 3 study

scientific article published on 19 June 2017

Effects of nonpharmacological therapies on anxiety and cortisol: A meta-analysis

scientific article published in May 2018

Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial ⬇️

scientific article published on February 21, 2013

Efficacy and safety of adjunctive bitopertin (5 and 10mg) versus placebo in subjects with persistent predominant negative symptoms of schizophrenia treated with antipsychotics — Results from the phase III DayLyte study

Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder

scientific article published on December 2004

Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data

scientific article published on 29 August 2018

Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia

scientific article

Elevating the standard of care in the management of cardiometabolic risk factors in patients with mental illness. Conclusion: summary and recommendations.

scientific article published in June 2008

Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure

scientific article

Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study

scientific article published on 11 January 2017

Executive function impairment in first-degree relatives of persons with schizophrenia: A meta-analysis of controlled studies ⬇️

scientific article published on May 28, 2011

Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

scientific article

Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy

scientific article published on 01 July 2016

Factors in antipsychotic drug selection: tolerability considerations

scientific article published in November 2003

Focus on lower risk of tardive dyskinesia with atypical antipsychotics

scientific article

Gender Differences in the Etiology and Symptoms of Schizophrenia Genetic Versus Brain Injury Factors

Growing our own: a regional approach to encourage psychiatric residents to enter research

scientific article published in May 2008

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus

scientific article published on 01 December 2018

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus

scientific article published on 01 October 2019

Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone

scientific article published in April 2004

Hippocampal dysfunction in Gulf War Syndrome. A proton MR spectroscopy study

scientific article published in May 2004

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.

scientific article published on 04 June 2008

Impaired plasmalogens in patients with schizophrenia

scientific article published on 16 April 2012

Improving patient outcomes in schizophrenia: achieving remission

scientific article published on November 2006

Improving the pedagogy associated with the teaching of psychopharmacology

scientific article published in May 2007

Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?

scientific article published on 25 April 2018

Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.

scientific article published on 29 July 2009

Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond

scientific article published in January 2007

Linkage of cognitive impairments with metabolic disorders in schizophrenia

scientific article published on 01 October 2010

Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics

scientific article (publication date: 2013)

Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial

scientific article published on 14 July 2016

Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia

scientific article published on 15 August 2018

Low high-density lipoprotein and psychopathology: A review

scientific article published on 01 August 2019

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

scientific article

Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol: preliminary analysis of retrospective data

scientific article

Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study ⬇️

scientific article published on February 17, 2013

Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies

scientific article published on 23 June 2014

Measurement-based Care in Psychiatry-Past, Present, and Future.

scientific article published in November 2018

Memantine normalizes brain activity in the inferior frontal gyrus: a controlled pilot fMRI study

scientific article published on 12 September 2007

Meta-analysis trends in schizophrenia over three decades

scientific article published on 01 March 2009

Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil

scientific article published on August 2017

Metabolic findings from the CATIE trial and their relation to tolerability

scientific article published on 01 July 2006

Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.

scientific article published on January 2006

Multiple neurotoxic effects of haloperidol resulting in neuronal death

scientific article

Multiple retinal anomalies in schizophrenia

scientific article

NMDA receptor antagonists for depression: Critical considerations.

scientific article published on August 2015

Neurologic comorbidities in schizophrenia.

scientific article

Neurological disorders in schizophrenia

scientific article published on December 2009

Neuroprotective effects of the second generation antipsychotics

scientific article published on 11 April 2019

New drug developments in psychosis: Challenges, opportunities and strategies

scientific article published on 9 August 2016

On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not.

scientific article

Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients

scientific article published on 7 November 2007

Pain insensitivity in schizophrenia: trait or state marker?

scientific article

Paliperidone: a new extended-release oral atypical antipsychotic

scientific article published on October 2007

Pathological laughter and crying: A case series and proposal for a new classification

scientific article

Personal and social functioning in schizophrenia: defining a clinically meaningful measure of maintenance in relapse prevention

scientific article published in June 2010

Perspectives on the Positive and Negative Syndrome Scale (PANSS): Use, misuse, drawbacks, and a new alternative for schizophrenia research

scientific article published on February 2016

Pharmacoeconomic implications of adverse effects during antipsychotic drug therapy.

scientific article

Placebo-controlled augmentation trials of the antioxidant NAC in schizophrenia: A review

scientific article

Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania

scientific article published in October 2006

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

scientific article published on 30 August 2005

Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.

scientific article published in January 2009

Psychiatric and physical comorbidity in schizophrenia. Preface

scientific article published in December 2009

Racial differences in antipsychotic use: Claims database analysis of Medicaid-insured patients with schizophrenia

scientific article

Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapy

scientific article published on 01 November 2006

Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs

scientific article

Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients

scientific article published on 26 August 2009

Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia

scientific article

Remission in schizophrenia: Applying recent consensus criteria to refine the concept

scientific article published on 31 August 2007

Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine

scientific article published on January 2007

Risperidone in the treatment of delirium: results from a prospective open-label trial

scientific article published on May 2004

S114. EFFICACY OF THE SEROTONIN 5HT-2A INVERSE AGONIST PIMAVANSERIN IN REFRACTORY HALLUCINATIONS AND DELUSIONS THAT FAILED TO RESPOND TO CLOZAPINE OR OTHER ANTIPSYCHOTICS

article published in 2019

Schizophrenia and aging: no more dearth of data?

scientific article published in November 2003

Schizophrenia and obsessive-compulsive disorder

scientific article published on November 2010

Schizophrenia, "just the facts" 4. Clinical features and conceptualization

scientific article published on 27 March 2009

Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future

scientific article published on 23 July 2010

Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology

scientific article

Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology

scientific article published on 16 September 2008

Schizophrenia, “Just the Facts” 6. Moving ahead with the schizophrenia concept: From the elephant to the mouse ⬇️

scientific article (publication date: April 2011)

Schizophrenia, “Just the Facts”: What we know in 2008

scientific article

Self-Reported Training Adequacy, Experience, and Comfort Level in Performing Schizophrenia-Related Clinical Skills among Psychiatry Residents and Fellows

scientific article published on 14 October 2016

Single-voxel proton MR spectroscopy of right versus left hippocampi in PTSD.

scientific article published in June 2003

Strategies for maximizing clinical effectiveness in the treatment of schizophrenia

scientific article published on November 2006

Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses

scientific article published in August 2006

Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist

scientific article published on 02 March 2019

Suicide Note Classification Using Natural Language Processing: A Content Analysis ⬇️

scientific article published on August 4, 2010

Supplement Issue

scientific article published on 01 January 2008

Temporal sequence of clinical manifestation in schizophrenia with co-morbid OCD: review and meta-analysis

scientific article published on 20 August 2008

The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists

scientific article published on 01 October 2004

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

scientific article published on 24 August 2005

The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review

scholarly article by Gianluca Serafini published in August 2018

The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: a focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization

scientific article

The association between weight change and symptom reduction in the CATIE schizophrenia trial ⬇️

scientific article published on February 21, 2011

The effects of yoga on depression and motor function in patients with Parkinson's disease: A review of controlled studies

scientific article published on 01 August 2020

The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy

scientific article published in January 2006

The intense desire for healthy limb amputation: A dis-proprioceptive neuropsychiatric disorder

scientific article published on May 2017

The internal structure of the phenomenology of auditory verbal hallucinations ⬇️

scientific article published on June 1, 2003

The legacy of Richard Jed Wyatt (1939-2002).

scientific article published in September 2002

The pro- and con-debate about the at-risk state and early intervention: A commentary

scientific article published on 09 June 2020

The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.

scientific article published in January 2007

The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis

scientific article

The urgent need for monitoring and intervention to reduce metabolic risk factors in patients with schizophrenia

scientific article published on 01 June 2008

The use of memantine in neuropsychiatric disorders: An overview

scientific article published on 01 August 2018

The varieties of anomalous self experiences in schizophrenia: splitting of the mind at a crossroad.

scientific article published on 9 December 2013

Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats

scientific article published on 15 May 2006

Toward the era of transformational neuropsychiatry

scientific article published on 01 September 2015

Transcending Psychosis: The Complexity of Comorbidity in Schizophrenia

scientific article published on 30 March 2016

Translational and spectrum aspects of Schizophrenia Research: The rationale for new journal's new subheading

scientific article published on 27 December 2016

Treatment of bipolar disorder.

scientific article

Triple advantages of injectable long acting second generation antipsychotics: Relapse prevention, neuroprotection, and lower mortality

scientific article published on 3 March 2018

“Just the facts”: Meandering in schizophrenia's many forests ⬇️

scientific article published on March 30, 2011

Paulina is supported by:

About Paulina

Help